Abstract
The objective of this study is to highlight the fact that papillary thyroid microcarcinoma can be aggressive, requiring therapeutic management similar to that of other differentiated thyroid cancers. This 8-year retrospective study concerned 187 surgical patients managed in an ENT and Head and Neck surgery department for thyroid cancer. 65 patients were found to have papillary microcarcinoma. 41 microcarcinomas were considered to be aggressive because of the presence of several risk factors such as larger than 5 mm, multifocal microcarcinomas, capsular effraction, vascular embolus, tumour extension beyond the thyroid parenchyma and metastatic lymphadenopathy. All patients with aggressive papillary microcarcinoma were treated by total thyroidectomy and 131I. Ipsilateral recurrent laryngeal and lateral cervical lymph node dissections were performed in ten patients, ipsilateral cervical lymph node dissection was performed in six patients and bilateral recurrent laryngeal and lateral cervical lymph node dissections were performed in three patients. No recurrence or metastasis was observed (follow-up ranging from 6 months to 8 years). The optimal management of thyroid papillary microcarcinoma is still controversial. “Aggressive” papillary thyroid microcarcinoma is not rare and may justify aggressive treatment depending on the presence or absence of prognostic risk factors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Küçük NO, Tari P, Tokmak E, Aras G (2007) Treatment for microcarcinoma of the thyroid—clinical experience. Clin Nucl Med 32:279–281
Pelizzo MR, Boschin IM, Toniato A et al (2006) Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients. Eur J Surg Oncol 32:1144–1148
Cheema Y, Olson S, Elson D et al (2006) What is the biology and optimal treatment for papillary microcarcinoma of the thyroid? J Surg Res 134:160–162
Sakorafas GH, Giotakis J, Stafyla V (2005) Papillary thyroid microcarcinoma: a surgical perspective. Cancer Treat Rev 31:423–438
Orsenigo E, Beretta E, Fiacco E et al (2004) Management of papillary microcarcinoma of the thyroid gland. Eur J Surg Oncol 30:1104–1106
Pelizzo MR, Boschin IM, Toniato A et al (2004) Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience. Nucl Med Commun 25:547–552
Ito Y, Miyauchi A (2005) Therapeutic strategies for papillary microcarcinoma of the thyroid. Curr Cancer Ther Rev 1:19–25
Garrel R, Cartier C, Marvaso V et al (2002) Our experience with papillary microcarcinoma of the thyroid. Rev Laryngol Otol Rhinol (Bord) 123:239–242
Rodriguez JM, Moreno A, Parrilla P et al (1997) Papillary thyroid microcarcinoma: clinical study and prognosis. Eur J Surg 163:255–259
Dietlein M, Luyken WA, Schicha H et al (2005) Incidental multifocal papillary microcarcinomas of the thyroid: is subtotal thyroidectomy combined with radioiodine ablation enough? Nucl Med Commun 26:3–8
Ito Y, Tomoda C, Uruno T et al (2004) Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg 28:1115–1121
Ito Y, Uruno T, Nakano K et al (2003) An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13:381–387
Cooper DS, Doherty GM, Haugen BR et al (2006) The American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109–142
Baudin E, Travagli JP, Ropers J et al (1998) Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer 83:553–559
Castro MR, Gharib H (2005) Continuing controversies in the management of thyroid nodules. Ann Intern Med 142:926–931
Chen H, Udelsman R (1998) Papillary thyroid carcinoma: justification for total thyroidectomy and management of lymph node metastases. Surg Oncol Clin N Am 7:645–663
Ito Y, Tomoda C, Uruno T et al (2004) Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid. World J Surg 28:498–501
Yang GC, LiVolsi VA, Baloch ZW (2002) Thyroid microcarcinoma: fine-needle aspiration diagnosis and histologic follow-up. Int J Surg Pathol 10:133–139
Verge J, Guixa J, Alejo M et al (1999) Cervical cystic lymph node metastasis as first manifestation of occult papillary thyroid carcinoma: report of seven cases. Head Neck 21:370–374
Falvo L, D’Ercole C, Sorrenti S et al (2003) Papillary microcarcinoma of the thyroid gland: analysis of prognostic factors including histological subtype. Eur J Surg Suppl 588:28–32
Ríos A, Rodríguez JM, Canteras M et al (2004) Risk factors for malignancy in multinodular goitres. Eur J Surg Oncol 30:58–62
Appetecchia M, Scarcello G, Pucci E et al (2002) Outcome after treatment of papillary thyroid microcarcinoma. J Exp Clin Cancer Res 21:159–164
Chow SM, Law SC, Chan JK et al (2003) Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Cancer 98:31–40
Conflict of interest statement
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Page, C., Biet, A., Boute, P. et al. ‘Aggressive papillary’ thyroid microcarcinoma. Eur Arch Otorhinolaryngol 266, 1959–1963 (2009). https://doi.org/10.1007/s00405-009-0952-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-009-0952-5